Join us as we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study. You’ll learn about the innovative approaches used to assess the effectiveness of MCED tests, the collaboration with leading health systems, and the potential to transform early cancer detection globally.

Explore case studies and opportunities leveraging Aspen, a prospective and retrospective study automation platform and evidence generation solution that enables rapid, cost-effective, and scalable research.